Sign in
CompletedNo phase

Philly NavSTAR Implementation Trial

Key facts

Who runs it
Friends Research Institute, Inc.
Where
Philadelphia, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
32 people enrolled
Started
9 Aug 2024
Ended
31 Aug 2025
Type of study
Interventional
Treatments tested
  • NavSTAR (Philly adaptation)
Record updated
29 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • age 18 or older
  • current DSM-5 criteria for moderate to severe OUD
  • willing and able to provide informed consent in English

Who cannot take part

  • enrollment in OUD treatment 30-days prior to hospitalization
  • residency outside the City of Philadelphia
  • pregnancy
  • planned discharge to a long-term inpatient care facility (e.g., hospice)
  • hospitalization for a suicide attempt

Where in United States

  • Friends Research InstitutePhiladelphia, United States
  • Jefferson HealthPhiladelphia, United States

About the trial

What the trial wants to find out

Patient Navigation (PN) interventions following hospitalization can reduce the differences that certain groups have been trying to access opioid use disorder treatment. These differences, which affect racial minority groups the most, contribute to the opioid overdose epidemic. However, delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to find solutions to these significant barriers by engaging community, hospital, and patient partners. This study is being conducted to learn more about how to implement NavSTAR, a patient navigation intervention for people with opioid use disorder, across a health system. Our research team showed in a previous study with 400 participants that NavSTAR significantly increased entry into opioid use disorder treatment, reduced readmissions to the hospital, and was highly cost- effective compared to treatment as usual. This study will first pilot NavSTAR with 32 patient participants across 4 hospitals in the City of Philadelphia. Then, we will conduct a large trial with 720 patient participants to see if we can reach people who need the intervention, and create a sustainable plan to continue the intervention after the grant award period.

The group in the trial

  • NavSTARTreatment being tested

    NavSTAR is a Patient Navigation service model to reduce internal and external barriers to recommended service engagement. It includes motivational interventions in tandem with proactive barrier resolution, targeting areas of addiction, medical, self-care, and basic needs.

    Treatment: NavSTAR (Philly adaptation)

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Implementing a Patient Navigation Intervention Across a Health System to Address Treatment Entry Inequities
Record updated
29 September 2025